Literature DB >> 15231426

Voltammetric behaviour of rabeprazole at a glassy carbon electrode and its determination in tablet dosage form.

A Radi1, N Abd El-Ghany, T Wahdan.   

Abstract

The oxidative behaviour of rabeprazole was studied at a glassy carbon electrode in Britton-Robinson (BR) buffer solutions using cyclic, linear sweep and differential-pulse voltammetry. The oxidation process was shown to be irreversible over the pH range (6.0-11.0) and was diffusion-adsorption controlled. An analytical method was developed for the determination of rabeprazole in BR buffer solution at pH 8.0 as supporting electrolyte. The anodic peak current varied linearly with rabeprazole concentration in the range 1.0 x 10(-6) to 2.0 x 10(-5) M of rabeprazole with a limit of detection of 4.0 x 10(-7) M. Validation parameters, such as sensitivity, accuracy, precision and recovery, were evaluated. The proposed method was applied to the determination of rabeprazole in the tablet dosage form. The results were compared with those obtained by a published high-performance liquid chromatographic method. No difference was found statistically.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15231426     DOI: 10.1016/j.farmac.2004.03.009

Source DB:  PubMed          Journal:  Farmaco        ISSN: 0014-827X


  3 in total

1.  Spectrophotometric determination of certain benzimidazole proton pump inhibitors.

Authors:  A A Syed; Ayesha Syeda
Journal:  Indian J Pharm Sci       Date:  2008 Jul-Aug       Impact factor: 0.975

2.  Validation and application of a new reversed phase HPLC method for in vitro dissolution studies of rabeprazole sodium in delayed-release tablets.

Authors:  Md Saddam Nawaz
Journal:  J Anal Methods Chem       Date:  2013-08-22       Impact factor: 2.193

3.  Development and validation of dissolution testings in acidic media for rabeprazole sodium delayed-release capsules.

Authors:  Yinhe Tan; Xiaoqing Si; Lulu Zhong; Xin Feng; Xinmin Yang; Min Huang; Chuanbin Wu
Journal:  Drug Dev Ind Pharm       Date:  2016-04-11       Impact factor: 3.225

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.